ATR and metabolic dysfunction-associated steatotic liver disease: ATR is a high-affinity specific inhibitor of ANT; the depletion or chemical inhibition of ANT2 improves the liver steatosis by reducing hepatic TG level (Cho et al., 2017), implying the potential effect of ATR on NAFLD treatment.